bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Endolymphatic Stromal Myosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davidson, R; Feig, B; Hu, W; Khokhar, AR; Kumagai, S; Lee, SJ; Maclean, DS; Mansfield, P; Siddik, ZH; Verschraegen, CF | 1 |
1 trial(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Endolymphatic Stromal Myosis
Article | Year |
---|---|
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Ascites; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; Endometrial Stromal Tumors; Female; Humans; Injections, Intraperitoneal; Liposomes; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Radionuclide Imaging; Technetium; Tissue Distribution | 2003 |